1.Plasmacytoma presented as a lid mass: A case report.
Woo Jeong CHOI ; Hungwon TCHAH ; Yong J KIM
Korean Journal of Ophthalmology 1991;5(2):92-95
A solitary lid mass was identified as a primary solitary plasmacytoma. A 71 year old male presented with a left upper lid mass. The mass was found to be firmly intermingled with the underlying tarsal plate. A total excision was successfully performed and the lid margin was reconstructed with a good cosmetic result. There were no positive findings in the systemic work-up. The light microscopic findings suggest that the mass is of tarsal plate origin. It is the first case of plasmacytoma of tarsal plate origin presented as a lid mass.
Aged
;
Eyelid Neoplasms/*diagnosis/surgery
;
Humans
;
Male
;
Plasmacytoma/*diagnosis/surgery
2.Mandibular plasmacytoma: a case report.
Journal of Zhejiang University. Medical sciences 2011;40(1):112-114
3.Clinical study of solitary bone plasmacytoma.
Tai-qiang YAN ; Wei GUO ; Xiao-dong TANG ; Shun TANG
Chinese Journal of Surgery 2003;41(10):749-752
OBJECTIVETo study the clinical characteristics and the prognosis of solitary bone plasmacytoma (SBP).
METHODSFrom June 1997 to June 2002, ten SBP patients were treated in our department. Two lesions were in sacrum, two in pelvis, the other six lesions were in proximal femur, femoral diaphyseal, scapula, thoracic vertebra, proximal humus, and rib respectively. The preoperative laboratory tests were normal. Operation was performed on all patients. The pathologic diagnose was plasmacytoma and then they underwent further laboratory examination, urine Bence-Jone protein is positive in 3 patients, serous IgG value was higher than normal in 2 patients, abnormal M protein was found in electrophoresis in 2 patients. All patients received radiotherapy postoperatively.
RESULTSFour patients were excluded, whose follow-up were lessen than ten months, the other six patients's average follow-up is 28.2 months (from 18 to 48 months), one patient who developed multiple myeloma (MM) six months postoperatively received chemotherapy using M2 protocol and died 21 months after operation. The other five patients had disease-free survive and remain solitary bone lesion after the treatment of surgery and radiology.
CONCLUSIONCompared with MM, SBP patients are younger, the therapeutic results and prognosis are better. The main prognostic factors include age, the size of lesion, the axial bone lesion, persistence of myeloma protein after radiotherapy, early diagnosis and treatment, and so on.
Bone Neoplasms ; diagnostic imaging ; surgery ; Female ; Humans ; Male ; Middle Aged ; Plasmacytoma ; diagnostic imaging ; surgery ; Prognosis ; Radiography
4.A case of huge extramedullary plasmacytoma in the retropharyngeal space.
Gaoya QU ; Qingbao LONG ; Xing YAN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(10):953-954
Extramedullary plasmacytoma (EMP) are often located in the head and neck region, commonly affecting the nasal cavity, tonsillar fossa and oral cavity but rarely the retropharyngeal space. In this report, a 60-year-old woman with large EMP in the retropharyngeal space is presented, who was diagnosed by pathology, bone marrow aspirate and computed tomography scan. The patient received operation and postoperative radiotherapy with dose of 50 Gy. At sixteen months follow-up, the patient was doing well with no signs of recurrence.
Female
;
Humans
;
Middle Aged
;
Nasal Cavity
;
pathology
;
Plasmacytoma
;
pathology
;
radiotherapy
;
surgery
;
Tomography, X-Ray Computed
5.Recent Research Progress of Extramedullary Plasmacytoma --Review.
Ning LIU ; Juan ZHAO ; X I YUAN ; Ya-Ming XI
Journal of Experimental Hematology 2023;31(2):607-611
Extramedullary plasma cell tumor (EMP) is a kind of plasma cell tumor, and its pathogenesis is not completely clear. According to whether it is independent of myeloma disease, it can be divided into primary and secondary EMP, which have different biological and clinical characteristics. Primary EMP has low invasion, fewer cytogenetic and molecular genetic abnormalities and good prognosis, and surgery and / or radiotherapy are the mainly treatments. Secondary EMP, as the extramedullary invasive progression of multiple myeloma (MM), is often accompanied by high-risk cellular and molecular genetic abnormalities and poor prognosis, chemotherapy, immunotherapy and hematopoietic stem cell transplantation are the mainly treatment. This paper reviews the latest research progress of EMP in the pathogenesis, cytogenetics molecular genetics and treatment, so as to provide reference for clinical work.
Humans
;
Plasmacytoma/surgery*
;
Prognosis
;
Multiple Myeloma/genetics*
;
Hematopoietic Stem Cell Transplantation
6.Clinical analysis of 10 cases with extramedullary plasmacytoma of the head and neck.
Jun Fu WU ; Li Yuan DAI ; Meng CUI ; Gang LI ; Lu FENG ; Rui Hua LUO ; Wei DU ; Shan Ting LIU
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2022;57(2):197-200
Objective: To explore the clinical characteristics, treatment methods and outcomes of extramedullary plasmacytoma of the head and neck. Methods: A retrospective analysis was conducted on 10 cases with extramedullary plasmacytoma of the head and neck who were admitted to Henan Tumor Hospital from January 2005 to January 2020. Among the 10 patients, 6 were male and 4 were female. The average age at diagnosis was 56.3 years old (34-74 years old). Among them, 3 cases were located in the nasal cavity, 2 cases in the nasopharynx, 1 case in the sinuses, 2 cases in the larynx, 1 case in the oropharynx, and 1 case in the cervical lymph nodes. Treatments were administered according to tumor size and resection extent. Complete surgical excision (negative margins) was preferred, followed by adjuvant radiotherapy or radiotherapy alone. The clinical characteristics, diagnosis, treatment and prognosis of EMP were analyzed. Results: The patients' symptoms were not specific, frequently with local obstruction symptom and localized masses. All patients were confirmed pathologically as suffering from monoclonal plasmacytoma, with negative bone marrow biopsy and negative skeletal survey. Five patients received surgery, 3 received radiotherapy, and 2 received surgery with additional radiation. The follow-up time was 16-125 months, with a median of 92 months. Two patients developed into multiple myeloma. One patient who received radiotherapy after surgery relapsed after 7 years of follow-up and again received surgical treatment, with no evidence of second recurrence. The remaining patients had no recurrence or progression. Conclusion: Extramedullary plasmacytoma of the head and neck has a good prognosis. Surgical treatment can be considered for completely resectable lesions.
Adult
;
Aged
;
Female
;
Head and Neck Neoplasms/therapy*
;
Humans
;
Male
;
Middle Aged
;
Multiple Myeloma/pathology*
;
Plasmacytoma/surgery*
;
Prognosis
;
Retrospective Studies
7.Extramedullary Plasmacytoma Involving the Bilateral Adrenal Glands on MR Imaging.
Yuan LI ; Ying Kun GUO ; Zhi Gang YANG ; En Sen MA ; Peng Qiu MIN
Korean Journal of Radiology 2007;8(3):246-248
We report here on a 64-year-old woman with extramedullary plasmacytoma involving the bilateral adrenal glands. Primary adrenal extramedullary plasmacytoma is extremely rare and only three cases of extramedullary plasmacytoma in the unilateral adrenal gland have currently been reported on. This case is of interest in that the bilateral adrenals were involved. In this article, we present the MRI findings and we briefly review the relevant literature.
Adrenal Gland Neoplasms/*diagnosis/surgery
;
Back Pain/etiology
;
Female
;
Humans
;
Kidney/pathology
;
*Magnetic Resonance Imaging
;
Middle Aged
;
Neoplasm Invasiveness
;
Plasmacytoma/*diagnosis/surgery
;
Vena Cava, Inferior/pathology
8.Surgical intervention and radiotherapy outcome of solitary plasmacytoma of cervical spine.
Wen-ding HUANG ; Da-peng FENG ; Jian-ru XIAO ; Quan HUANG ; Wei ZHENG ; Zhi-peng WU ; Zhen-hua ZHOU ; Xing-hai YANG ; Ning XIE
Chinese Journal of Surgery 2010;48(9):697-701
OBJECTIVETo study the clinical features, treatment methods and outcome of solitary plasmacytoma of cervical spine.
METHODSFrom January 1995 to December 2007, the data of 23 cases with solitary plasmacytoma of cervical spine was analyzed. There were 16 males and 7 females (mean age 56 years, range: 32 - 76 years). Two cases underwent radiotherapy alone and 21 patients received surgery. According to WBB staging system, surgical procedures were defined as total or subtotal resection (6 cases), appendix resection (4 cases), sagittal resection (3 cases) and total spondylectomy (8 cases). All surgical cases were managed using an anterior approach, posterior approach or combined anterior and posterior approach. The cervical spinal reconstruction was achieved through anterior cervical titanium plate and titanium mesh cage filled with auto iliac graft or bone cement, or anterior and posterior combined instrumented fusion. All patients received radiotherapy as adjunctive therapy.
RESULTSFollow-up of the 23 cases lasted 24.0 - 143.0 months (mean: 64.7 months). Neck pains obviously improved, and nerve compression symptoms disappeared or improved after surgery. Neurological function improved by 1 - 2 grades based on Frankel grading system. All the internal fixations were fused well and stability of the cervical spine was fine and no spine instability could be seen in our series. The bone graft fusion rate was 100%. During the follow-up period, 6 surgical cases had local recurrence and finally progressed to multiple myeloma (MM) and 3 died. Two cases without surgical treatment progressed to MM in 1 year and 1.5 years after confirmed diagnosis. They were given systemic chemotherapy. The other 15 patients had disease-free survival and after surgery and adjunctive radiotherapy. Obvious abnormity were not found in such examinations as M protein, bone marrow aspiration and emission computed tomography or PET-CT examinations.
CONCLUSIONSSolitary plasmacytoma of cervical spine is rarely seen clinically. Surgery is recommended as the primary management for patients with overt bone destruction and spinal instability or neurological dysfunction. Tumor excision with adjunctive radiotherapy can obviously reduce local recurrences and lower the possibility of progression to MM. The patients with progression to MM should receive chemotherapy according to chemotherapy protocol while the prognosis is comparatively worse.
Adult ; Aged ; Cervical Vertebrae ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Plasmacytoma ; surgery ; Retrospective Studies ; Spinal Neoplasms ; surgery ; Treatment Outcome
9.A Case of Primary Plasmacytoma of Lymph Nodes.
Young Hyo LIM ; Su Kyoung PARK ; Ho Suk OH ; Jung Hye CHOI ; Myung Ju AHN ; Young Yul LEE ; In Soon KIM
The Korean Journal of Internal Medicine 2005;20(2):183-186
Extramedullary plasmacytoma may originate in any organ, either as a primary tumor or as a facet of systemic multiple myeloma. These solid lesions most commonly affect the upper respiratory tract, gastrointestinal and urogenital tract, skin, and lung. Primary plasmacytoma of the lymph node is a rare hematologic neoplasm, which usually manifests as an enlargement of the cervical lymph nodes with no evidence of any other plasma cell dyscrasia. A 56-year-old man was admitted, due to the presence of multiple palpable masses in the right cervical and submandibular areas. Surgical resection revealed plasmacytoma of the lymph nodes. According to our full work-up, no evidence of the systemic involvement of plasma cell dyscrasia was discovered and thus, the diagnosis of primary plasmacytoma of the lymph node was made. Radiotherapy was administered, and the remnant mass was reduced substantially, to 1 x 2 cm in size. The patient was scheduled to be monitored by a PET CT scan, as well as by a neck CT scan.
Biopsy, Needle
;
Bone Marrow/pathology
;
Diagnosis, Differential
;
Humans
;
Lymph Node Excision
;
*Lymph Nodes/pathology/radiography
;
Male
;
Middle Aged
;
Neck
;
Plasmacytoma/*diagnosis/surgery
;
Tomography, X-Ray Computed
10.Epstein-Barr virus positive anaplastic-like plasmacytoma: report of a case.
Wen-sheng LI ; Xiao-ge ZHOU ; Jian-lan XIE
Chinese Journal of Pathology 2013;42(3):203-204
ADP-ribosyl Cyclase 1
;
metabolism
;
Aged
;
Epstein-Barr Virus Infections
;
Herpesvirus 4, Human
;
isolation & purification
;
Humans
;
Interferon Regulatory Factors
;
metabolism
;
Ki-67 Antigen
;
metabolism
;
Male
;
Nasal Cavity
;
Nose Neoplasms
;
metabolism
;
pathology
;
surgery
;
virology
;
Plasmacytoma
;
metabolism
;
pathology
;
surgery
;
virology